Article info
PDFNarrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective
Citation
Narrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective
Publication history
- First published February 1, 2000.
Online issue publication
February 01, 2000
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2000 by the Journal of Medical Ethics
Other content recommended for you
- Pathogenesis of Anemia During Human Immunodeficiency Virus Infection
- Cardiovascular manifestations of HIV infection
- HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism
- Update on antiretroviral therapy
- Post-exposure prophylaxis for HIV
- Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects
- Prospective cohort study of mortality in very low birthweight infants in a single centre in the Eastern Cape province, South Africa
- THE NEUROLOGY OF HIV INFECTION
- What’s new for injection drug users with HIV infection?
- Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus